tiprankstipranks
Theriva Biologics (TOVX)
XASE:TOVX
US Market
TOVX
Theriva Biologics
RESEARCH TOOLSreports

Theriva Biologics (TOVX) Income Statement

1,211 Followers

Theriva Biologics Income Statement

Last quarter (Q4 2025), Theriva Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Theriva Biologics's net income was $-3.51M. See Theriva Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -108.00K$ 0.00$ 0.00$ 0.00$ -87.00K
Operating Expenses
$ 14.91M$ 26.35M$ 21.43M$ 21.58M$ 14.27M
Depreciation and Amortization
$ 108.00K$ 137.00K$ 135.00K$ 85.00K$ 87.00K
EBITDA
$ -14.91M$ -19.29M$ -21.96M$ -19.20M$ -14.19M
Operating Income
$ -15.02M$ -26.35M$ -21.43M$ -21.58M$ -14.27M
Other Income/Expenses
$ -8.72M$ 693.00K$ 1.44M$ 471.00K$ 6.00K
Pretax Income
$ -23.74M$ -25.65M$ -19.99M$ -21.11M$ -14.27M
Net Income
$ -25.25M$ -25.65M$ -18.35M$ -19.68M$ -14.27M
Per Share Metrics
Basic EPS
$ -2.08$ -19.03$ -28.49$ -32.66$ -1.90
Diluted EPS
$ -2.08$ -19.03$ -28.48$ -32.66$ -1.90
Weighted Average Shares Outstanding
 12.14M 1.35M 644.00K 613.09K 12.19M
Weighted Average Shares Outstanding (Diluted)
 12.14M 1.35M 644.28K 613.09K 12.19M
Currency in USD

Theriva Biologics Earnings and Revenue History